360iResearch Logo
Global Immuno Oncology Assays Market
Report Code: MRR-CF4288D | Publishing Date: May 2020 | Number of Pages: 235
Global Immuno Oncology Assays Market | Market Research Report | Cumulative Impact of COVID-19

Market Dynamics:

The factors attributing to the growth of the market are adoption of targeted therapy over other treatment options, growing incidences of cancer, rise in healthcare expenditure and healthcare insurance, technological advancement and r&d for the treatment of cancer, and development of bioinformatic tools enhancing the drug development process. However, some factors such as unfavorable regulatory and reimbursement scenario may hinder the market growth. The Immuno Oncology Assays Market is expected to showcase the opportunities such as companion diagnostics have the potential to improve immunotherapy efficacy and ensure greater safety and clinical trials to cure different cancers in immunotherapy. In the near future market may face the possible challenges in the growth due to cancer limiting the immune response. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Immuno Oncology Assays Market.

Market Segmentation & Coverage:

The research report categorizes the Immuno Oncology Assays Market to forecast the revenues and analyze the trends in each of the following segments:

On the basis of Indication, the Immuno Oncology Assays Market is studied across Bladder Cancer, Colorectal Cancer, Lung Cancer, and Melanoma.

On the basis of Product, the Immuno Oncology Assays Market is studied across Consumables and Software.

On the basis of Technology, the Immuno Oncology Assays Market is studied across Flow Cytometry, Immunoassay, Ngs, and PCR.

On the basis of Application, the Immuno Oncology Assays Market is studied across Clinical Diagnostics and Research.

On the basis of Geography, the Immuno Oncology Assays Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The Immuno Oncology Assays Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Immuno Oncology Assays Market including Agilent Technologies, Inc., Foundation Medicine, HTG Molecular Diagnostics, Inc., Illumina, Inc., Merck, Nanostring Technologies, Inc., Perkinelmer, Qiagen, Roche Diagnostics, Sartorius AG, and Thermo Fisher Scientific, Inc..

Scope of the Report:

AttributeDetails
Base Year for Estimation2019
Historical Period2017 - 2018
Estimation Period2020 - 2021
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Immuno Oncology Assays Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Immuno Oncology Assays Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Immuno Oncology Assays Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Immuno Oncology Assays Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Immuno Oncology Assays Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Immuno Oncology Assays Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Immuno Oncology Assays Market.
  • Evaluate the key vendors in the Immuno Oncology Assays Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Research Process
      1. Define: Research Objective
      2. Determine: Research Design
      3. Prepare: Research Instrument
      4. Collect: Data Source
      5. Analyze: Data Interpretation
      6. Formulate: Data Verification
      7. Publish: Research Report
    2. Research Execution
      1. Initiation: Research Process
      2. Planning: Develop Research Plan
      3. Execution: Conduct Research
      4. Verification: Finding & Analysis
      5. Publication: Research Report
    3. Research Outcome
      1. 360iResearch Market Share Analysis
      2. 360iResearch Competitive Strategic Window
  3. Executive Summary
    1. Market Outlook
    2. Indication Outlook
    3. Product Outlook
    4. Technology Outlook
    5. Application Outlook
    6. Geography Outlook
    7. Competitor Outlook
  4. Market Overview
    1. Introduction
    2. Immuno Oncology Assays Market, By Geography
  5. Market Dynamics
    1. Introduction
      1. Drivers
        1. Growing incidences of cancer
        2. Adoption of targeted therapy over other treatment options
        3. Development of bioinformatic tools enhancing the drug development process
        4. Rise in healthcare expenditure and healthcare insurance
        5. Technological advancement and R&D for the treatment of cancer
      2. Restraints
        1. Unfavorable regulatory and reimbursement scenario
      3. Opportunities
        1. Clinical trials to cure different cancers in immunotherapy
        2. Companion diagnostics have the potential to improve immunotherapy efficacy and ensure greater safety
      4. Challenges
        1. Cancer limiting the immune response
  6. Market Insights
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Cumulative Impact of COVID-19
    3. Client Customizations
  7. Global Immuno Oncology Assays Market, By Indication
    1. Introduction
    2. Bladder Cancer
    3. Colorectal Cancer
    4. Lung Cancer
    5. Melanoma
  8. Global Immuno Oncology Assays Market, By Product
    1. Introduction
    2. Consumables
    3. Software
  9. Global Immuno Oncology Assays Market, By Technology
    1. Introduction
    2. Flow Cytometry
    3. Immunoassay
    4. Ngs
    5. PCR
  10. Global Immuno Oncology Assays Market, By Application
    1. Introduction
    2. Clinical Diagnostics
    3. Research
  11. Americas Immuno Oncology Assays Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  12. Asia-Pacific Immuno Oncology Assays Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  13. Europe, Middle East & Africa Immuno Oncology Assays Market
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  14. Competitive Landscape
    1. 360iResearch FPNV Positioning Matrix
      1. Quadrants
      2. Business Strategy
      3. Product Satisfaction
    2. 360iResearch Market Ranking Analysis
    3. 360iResearch Market Share Analysis
    4. Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
  15. Company Usability Profiles
    1. Agilent Technologies, Inc.
    2. Foundation Medicine
    3. HTG Molecular Diagnostics, Inc.
    4. Illumina, Inc.
    5. Merck
    6. Nanostring Technologies, Inc.
    7. Perkinelmer
    8. Qiagen
    9. Roche Diagnostics
    10. Sartorius AG
    11. Thermo Fisher Scientific, Inc.
  16. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2017-2025 (USD MILLION)
  2. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLADDER CANCER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COLORECTAL CANCER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  9. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  10. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SOFTWARE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  12. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  14. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NGS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  15. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PCR, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  16. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  17. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  18. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  19. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  20. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  21. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  22. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  23. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  24. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  25. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  26. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  27. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  28. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  29. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  30. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  31. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  32. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  33. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  34. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  35. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  36. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  37. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  38. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  39. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  40. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  41. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  42. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  43. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  44. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  45. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  46. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  47. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  48. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  49. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  50. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  51. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  52. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  53. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  54. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  55. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  56. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  57. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  58. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  59. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  60. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  61. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  62. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  63. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  64. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  65. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  66. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  67. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  68. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  69. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  70. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  71. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  72. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  73. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  74. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  75. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  76. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  77. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  78. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  79. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  80. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  81. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  82. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  83. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  84. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  85. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  86. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  87. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  88. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  89. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  90. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  91. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  92. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  93. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  94. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  95. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  96. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  97. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  98. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  99. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  100. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  101. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  102. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  103. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  104. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  105. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  106. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  107. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  108. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  109. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  110. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  111. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  112. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  113. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  114. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  115. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  116. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  117. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  118. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  119. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  120. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  121. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  122. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  123. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  124. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  125. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  126. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  127. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  128. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  129. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  130. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  131. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  132. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  133. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  134. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: SCORES
  135. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: BUSINESS STRATEGY
  136. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: PRODUCT SATISFACTION
  137. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: RANKING
  138. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: MERGER & ACQUISITION
  139. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: AGREEMENT, COLLABORATION & PARTNERSHIP
  140. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  141. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: INVESTMENT & FUNDING
  142. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: EDITION DETAILS
  143. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: LICENSE DETAILS
  144. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: RESEARCH PROCESS
  2. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: RESEARCH EXECUTION
  3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2019 VS 2025 (USD MILLION)
  4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
  6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
  7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
  8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  9. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET, BY TYPE
  10. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2017-2025 (USD MILLION)
  11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  13. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: MARKET DYNAMICS
  14. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: PORTERS FIVE FORCES ANALYSIS
  15. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2025 (USD MILLION)
  17. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
  18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2025 (USD MILLION)
  19. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
  20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2025 (USD MILLION)
  21. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
  22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2025 (USD MILLION)
  23. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  24. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  25. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  26. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  1. Agilent Technologies, Inc.
  2. Foundation Medicine
  3. HTG Molecular Diagnostics, Inc.
  4. Illumina, Inc.
  5. Merck
  6. Nanostring Technologies, Inc.
  7. Perkinelmer
  8. Qiagen
  9. Roche Diagnostics
  10. Sartorius AG
  11. Thermo Fisher Scientific, Inc.